跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SERENACE haloperidol 1.5 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
SERENACE haloperidol 1.5 mg tablet bottle
Approved
STANDARD
SERENACE haloperidol 1.5 mg tablet bottle
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 31, 2025
Approval ID
fc623fc0d467a4dd
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
fc623fc0d467a4dd
Product Name
SERENACE haloperidol 1.5 mg tablet bottle
Artg Id
10258
Artg Name
SERENACE haloperidol 1.5 mg tablet bottle
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
1991-08-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/acdab08fcc977efa722c8827e05ac110.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/13b7473a6936a110b1445032f83b7f6f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 31, 2025
Approval ID
fc623fc0d467a4dd
Type
Standard
Back to TGA Approvals